Last reviewed · How we verify

NCT06320795: SOUNDI

Prospective Study for the Clinical Validation of the Soundi Wearable Medical Device

Completed NA Last updated 7 August 2024
What this trial tests

NA trial testing SOUNDI in OSA in 50 participants. Completed in 30 April 2024.

Timeline
22 November 2023
Primary endpoint
30 April 2024
30 April 2024

Quick facts

Lead sponsorBiocubica srl
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment50
Start date22 November 2023
Primary completion30 April 2024
Estimated completion30 April 2024
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Biocubica srl

Who can join

Adults 20 to 70, any sex, with OSA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pre-marketing, single-centre, prospective clinical trial with the aim of comparison the effectiveness and safety of the SOUNDI medical device compared to polysomnography in detecting parameters for the diagnosis of obstructive sleep apnea (OSA) syndrome in subjects with suspected diagnosis of sleep disorders.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical validation of a multisensor wearable device (SOUNDI) for the diagnosis of obstructive sleep apnea (OSA).
    Salito C, Bovio D, Lombardi C. · · 2026 · PMID 41559161 · DOI 10.1038/s41598-026-36290-y

Verify or expand the search:

Other recruiting trials for OSA

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06320795.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing